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Summary
 
The Src family tyrosine kinases Lck and Fyn are critical for signaling via the T cell receptor.
However, the exact mechanism of their activation is unknown. Recent crystal structures of Src
kinases suggest that an important mechanism of kinase activation is via engagement of the Src
homology (SH)3 domain by proline-containing sequences. To test this hypothesis, we identi-
fied several T cell membrane proteins that contain potential SH3 ligands. Here we demonstrate
that Lck and Fyn can be activated by proline motifs in the CD28 and CD2 proteins, respectively.
Supporting a role for Lck in CD28 signaling, we demonstrate that CD28 signaling in both
transformed and primary T cells requires Lck as well as proline residues in CD28. These data
suggest that Lck plays an essential role in CD28 costimulation.
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E
 
ngagement of the TCR by antigen triggers a cascade of
biochemical signaling events that culminates in T cell
activation. Work over the last 10 years has demonstrated
that the initial TCR signals are mediated by the activation
of the Src family tyrosine kinases Lck and Fyn (for a review
see reference 1). Lck and Fyn phosphorylate a conserved ty-
rosine motif known as the ITAM (immunoreceptor tyro-
sine-based activation motif),
 
1
 
 which is present multiple
times in the TCR complex. Upon phosphorylation of the
ITAM, another tyrosine kinase, ZAP-70, is recruited to the
TCR complex and phosphorylates a variety of downstream
substrates, leading to T cell activation.
Surprisingly, the mechanism of Lck and Fyn activation
by TCR engagement is not currently known. Until recently,
Src family tyrosine kinases were thought to be regulated
mainly by phosphorylation of a critical COOH-terminal
tyrosine residue (1–3). Phosphorylation of this tyrosine res-
idue inhibits kinase activity, whereas dephosphorylation
stimulates activity. However, in resting T cells that express
the tyrosine phosphatase CD45, most of the Lck and Fyn
molecules are already dephosphorylated at the COOH-ter-
minal tyrosine and should therefore be in an active state (4,
5). Thus, it is unclear how Lck and Fyn could be further
activated during T cell activation.
The recently solved crystal structures for the Src kinases Src
and Hck demonstrate how phosphorylation of the COOH
terminus inhibits kinase activity and also suggests an addi-
tional mechanism of kinase regulation (6, 7). The phosphor-
ylated COOH-terminal tyrosine interacts intramolecularly
with the Src homology (SH)2 domain, which restricts move-
ment of the lower lobe of the kinase domain. These crystal
structures also demonstrate that the SH3 domain is tethered
to the upper lobe of the kinase domain via an intramolecu-
lar interaction with a proline motif contained in a protein
segment that links the SH2 domain with the kinase domain
(SH2 linker). This suggests that release of both the SH3
and SH2 domains will be important in achieving full kinase
activity. Indeed, Moarefi et al. (8) showed that incubation
of Hck with a peptide ligand for the SH3 and/or the SH2
domain could stimulate kinase activity. This increase in ki-
nase activity is likely to be an important physiological mech-
anism for Src kinase regulation, because binding of HIV-
Nef to the SH3 domain of Hck can activate kinase activity
to levels sufficient to transform cells (9). Furthermore, c-Src
kinase activity can be induced by coexpression with an
SH3 binding protein, SIN, in 293 cells (10).
SH3-mediated kinase regulation has significant implications
for our understanding of T cell activation. As most of the Lck
and Fyn molecules in resting T cells lack COOH-terminal
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Abbreviations used in this paper: 
 
GST, glutathione S transferase; ITAM, im-
munoreceptor tyrosine-based activation motif; MAP, mitogen-activated
protein; SH, Src homology.  
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tyrosine phosphorylation, SH3 interactions could represent
the major mechanism of Src kinase activation during TCR
engagement. Thus, it will be important to identify proteins
containing ligands for the SH3 domains of Lck and Fyn
and determine whether they can regulate kinase activation.
Here, we demonstrate that sequences from the T cell ac-
cessory proteins CD2 and CD28 can activate Fyn and Lck
via interactions with their SH3 domains. CD2 has been
mainly implicated in adhesion, whereas CD28 is thought to
provide a second signal, termed costimulation, important
for the activation of naive T cells. Our data suggest that one
function of CD28 may be to activate Lck via an SH3-medi-
ated interaction. In support of this hypothesis, we show
that the proline motif of CD28 that can activate Lck is also
essential for CD28 function in both T cell lines and pri-
mary T cells. CD28 signaling is also defective in cells lack-
ing or deficient in Lck expression. T cell costimulation,
therefore, involves the activation of Lck by CD28.
 
Materials and Methods
 
Peptides.
 
Peptides were synthesized, purified, and analyzed as
previously described (11). The peptides were synthesized on ei-
ther an ABI (model 432A; Perkin-Elmer Corp.) or a Symphony/
Multiplex synthesizer (Rainin Instruments Co.) using standard
FMOC (fluorenylmethoxycarbonyl) chemistry. Reagents for pep-
tide synthesis were purchased from ABI, Rainin, and Advanced
ChemTech. The peptides were purified by C
 
18
 
 reversed-phase
HPLC, and their identity was confirmed and their concentration
determined by amino acid analysis (Beckman model 6300; Beck-
man Instruments, Inc.). All peptides were shown to consist of a
single species of the correct molecular mass by mass spectrometry
(Washington University Mass Spectrometry Facility).
 
Protein Expression.
 
The full length tyrosine kinases Lck and
Fyn were expressed as glutathione S transferase (GST) fusion pro-
teins using baculovirus expression in Sf9 cells. Proteins were pu-
rified by glutathione chromatography.
 
In Vitro Kinase Assays.
 
Kinase assays were performed as described
by Moarefi et al. (8). In brief, peptides (1 mM) were preincubated
with purified kinases (1 
 
m
 
M) in a buffer containing 50 mM
Hepes, pH 7.4, 10 mM MnCl
 
2
 
, 100 
 
m
 
M sodium ortho vanadate,
and 50 
 
m
 
M ATP in 10 
 
m
 
l for 20 min on ice. [
 
g
 
-
 
32
 
P]ATP (10 
 
m
 
Ci)
and 500 
 
m
 
M peptide Src substrate (RRLEIDAHYAARG) were
added to the reaction to a final volume of 20 
 
m
 
l. Reactions were
run in triplicate at 30
 
8
 
C for 20 min and terminated with 10% cold
TCA. The terminated reactions were centrifuged, blotted onto
phosphocellulose paper, washed with 0.425% phosphoric acid,
and quantitated using a PhosphorImager
 
®
 
 (Molecular Dynamics).
 
Lck Binding Assays.
 
The DNA encoding the mouse CD28
cytoplasmic tail was generated using PCR and subcloned into
pGEX-KT at the BamHI site. The 
 
D
 
C mutant, which lacks the
sequences encoding the last 16 residues, was generated using in-
verse PCR. Purified GST proteins were incubated with cell ly-
sates prepared from Sf9 cells infected with an Lck-containing
baculovirus or with a control Sf9 lysate. Lysates were incubated at
4
 
8
 
C for 2–3 h before glutathione agarose beads were added.
Beads were washed three times in lysis buffer (1% NP-40, 300
mM NaCl, 25 mM Hepes, pH 8.0, 25 mM NaF, and 100 
 
m
 
M
Na
 
3
 
Vo
 
4
 
) and then subjected to in vitro kinase reactions with or
without exogenous substrate. Kinase reactions were performed as
described above using 10 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP. The reactions were
 
terminated in 10% TCA. Peptide substrate phosphorylation was
determined after blotting onto phosphocellulose paper; Lck and
GST-CD28 phosphorylation was assessed after SDS-PAGE.
Phosphorylation was quantitated using PhosphorImaging.
 
DNA Constructs and Mutants.
 
Mouse CD28 cDNA was modi-
fied with NotI and XbaI restriction sties at the 5
 
9
 
 and 3
 
9
 
 ends, re-
spectively, using PCR and subcloned into the pCDNA3.1 vector
(Invitrogen Corp.). COOH-terminal deletions (
 
D
 
16) and point
mutants (P187,190A) were generated by inverse PCR. All mu-
tated cDNAs were sequenced to verify their identities. The c-fos
promoter driving luciferase was provided by Dr. Philip Stork
(Vollum Institute, Portland, OR).
 
Transient Transfections.
 
Cycling Jurkat cells were resuspended
at 2 
 
3
 
 10
 
7
 
 cells/ml in RPMI plus 10% fetal bovine serum (FBS),
and 0.5 ml was placed into a 4-mm cuvette. Cells were incubated
at room temperature for 10 min with 5 
 
m
 
g vector plus 25 
 
m
 
g
CD28 construct or empty vector and electroporated in a BTX
ECM 600 at 300 V, 960 
 
m
 
F, and R9. Cells were allowed to re-
cover for 10 min at room temperature and then placed into pre-
warmed RPMI with 10% FBS. 10–12 h later, bulk cultures were
split and stimulated with antibodies to mCD28 (1 
 
m
 
g/ml) or
PMA (5 ng/ml). Cells were harvested 24 h later, lysed in hypo-
tonic lysis buffer (1 mM EDTA, pH 8.0, and 10 mM KH
 
2
 
PO
 
4
 
),
and assayed for luciferase activity. Transfection efficiency was
normalized to cytomegalovirus renilla luciferase activity (coelenter-
azine purchased from SeaLite Sciences, Inc.) and by immuno-
blotting and flow cytometry. JCaM1.6 cells lacking functional Lck
were electroporated under the following conditions: 300 V, 1050 
 
m
 
F,
R10. All other aspects of the transfection were performed as above.
 
Retroviral Infections and Proliferation.
 
Full length or mutant
mCD28 cDNA constructs were cloned into the retroviral vector
GFP-RV (provided by Dr. W. Sha, University of California Ber-
keley, Berkeley, CA) and transiently transfected into the Phoenix
E packaging cell line (provided by G. Nolan, Stanford University,
Palo Alto, CA) by chloroquine-mediated CaPO
 
4
 
 transfection. 48 h
after transfection, the retroviral supernatant was harvested and
used to infect lymph node cells from either wild-type C57Bl/6
mice (The Jackson Laboratory) or CD28-deficient mice in the
C57Bl/6 background (12) that had been activated 48 h previ-
ously with PMA (5 ng/ml) and ionomycin (0.1 
 
m
 
g/ml). In addi-
tion, the primary activation of CD28-deficient cells included 100
U/ml IL-2 to facilitate proliferation. T cells were cocultured with
the retroviral supernatant for 72 h and then washed in fresh media
and rested overnight. Infection efficiency was determined by flow
cytometric measurement of GFP expression and varied from 10 to
20% between experiments but was similar for each construct within
a given experiment. CD28 expression was confirmed by surface
staining with a PE-conjugated anti-CD28 mAb (PharMingen).
CD28-mediated costimulation was determined by a standard
proliferation assay. In brief, 7.5 
 
3
 
 10
 
4
 
 cells were plated in each well of
a round-bottom 96-well plate (Costar Corp.) and stimulated with
media, PMA (5 ng/ml), or PMA plus anti-CD28 (1.0 
 
m
 
g/ml; mAb
PV-1 provided by Dr. C. June, Naval Medical Research Institute,
Bethesda, MD). The cultures were pulsed with 1.0 
 
m
 
Ci tritiated thy-
midine (ICN Biomedicals, Inc.) for the final 12 h of a 36-h culture
and harvested with a Skatron 96-well plate harvester onto glass mi-
crofiber filtermats. The counts of incorporated thymidine were deter-
mined by liquid scintillation counting on a Wallach 1205 Betaplate.
 
Results
 
Peptides Based on Proline Motifs Contained in CD2 and
CD28 Can Activate Fyn and Lck In Vitro.
 
The crystal struc- 
377
 
Holdorf et al.
 
tures of Src and Hck show that in the inactive conforma-
tion of the kinase, the SH3 domain forms an intramolecu-
lar interaction with the SH2 linker region and the kinase
domain (6, 7). In solution, full kinase activation of Src and
Hck only occurs when both the COOH-terminal tyrosine
is dephosphorylated and the SH3 domain is displaced (8).
This observation led us to hypothesize that cellular proteins
containing SH3 binding motifs might be important to acti-
vate tyrosine kinases during TCR signaling.
The sequences of transmembrane proteins known to be
associated with the TCR were examined for the consensus
SH3 binding motif, PXXP (P,
 
 
 
proline and X,
 
 
 
any amino
acid) (13, 14). CD2, CD28, and CD3
 
e
 
 were found to con-
tain one or more PXXP sequences. CD3
 
e
 
 is an essential
component of the TCR complex and is critically involved
in T cell activation. CD2 has been mainly implicated in ad-
hesion, whereas CD28 provides a second signal, termed co-
stimulation, important for the activation of naive T cells.
Peptides of 15–20 residues were generated for each of
the potential SH3 binding sites in CD2, CD28, and CD3
 
e
 
.
CD2 contains five proline-rich regions, and CD28 and
CD3
 
e
 
 have two and one sites, respectively (Fig. 1 A). In
the case of the CD3
 
e
 
 peptide, the tyrosine in the peptide
was changed to phenylalanine to prevent it from being
used as a substrate in the kinase reaction, as this tyrosine is
the first tyrosine of the CD3
 
e
 
 ITAM.
Each of the peptides was tested for its ability to stimulate
the kinase activity of Lck and Fyn using in vitro kinase
reactions. Lck and Fyn proteins were purified from baculo-
virus-infected Sf9 cells as GST fusion proteins. Because Lck
and Fyn were expressed in the absence of Csk, the kinase
that phosphorylates the COOH-terminal tyrosine, the reg-
ulatory COOH-terminal tyrosine is not phosphorylated (6,
7). Thus, the only known mechanism for increasing kinase
activity, based on the crystal structures of Src and Hck, is
by displacement of the SH3 domain.
Enzymatic activity of purified Lck and Fyn was mea-
sured after the kinases were preincubated with each of the
peptides. One of the CD28 peptides (CD28-2) maximally
stimulated Lck kinase activity (Fig. 1 B). This threefold
magnitude of activation is in agreement with the maximum
level of activation predicted by Moarefi et al. (8). Thus,
COOH-terminally dephosphorylated Lck is fully activated
by a CD28 peptide.
The ability of the CD28-2 peptide to activate Lck was
specific, as the same peptide had no effect on the activity of
Fyn (Fig. 1 C). Conversely, a CD2 peptide (CD2-5) was
able to strongly stimulate Fyn kinase activity but had no ef-
fect on Lck (Fig. 1 C). This peptide, murine residues 294–
311, corresponds to the most highly conserved portion of
the CD2 cytoplasmic domain, suggesting that this interac-
tion may be physiologically relevant. In addition, these data
are consistent with previous results demonstrating that CD2
and CD28 can interact via their proline-rich tails with the
SH3 domains of Fyn and Lck (15–18). Our data extend
these previous findings by demonstrating that interactions
between CD2 and CD28 with Fyn and Lck, respectively,
can function to specifically activate these kinases.
 
Substitution of the Proline Residues with Alanine Abrogates
Kinase Activation.
 
To confirm that the proline residues are
responsible for regulating kinase activity, peptides were
synthesized containing alanine residues substituted for the
proline residues. Peptides were then retested for their abil-
ity to stimulate kinase activity (Fig. 2 A). Substitution of
Figure 1. Specific activation of Lck and
Fyn tyrosine kinases by CD2 and CD28
peptides in vitro. (A) Sequences of pep-
tides based on the cytoplasmic domain se-
quences of CD2, CD28, and CD3e are
shown using the one-letter amino acid
code. Phenylalanine was substituted for
tyrosine in the CD3e peptide to prevent
phosphorylation of this peptide in vitro.
(B) Activation of Lck in vitro by a CD28
peptide. Purified Lck was preincubated
with each of the peptides listed in A for
20 min on ice, and kinase activity was
measured using a Src substrate peptide and
[g-32P]ATP as described by Moarefi et al.
(8). Bar graphs represent fold activation of
kinases incubated with peptides as com-
pared with the activity of kinase incubated
with buffer and substrate alone. (C) Acti-
vation of Fyn in vitro by a CD2 peptide.
Kinase reactions were performed as in B
except that purified Fyn was used instead
of Lck. All data are representative of at
least three independent trials. 
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proline 187 and proline 190 (P187,190A) in the CD28-2
peptide completely abrogated the ability of the peptide to
activate Lck. Thus, the prolines in the CD28–2 peptide are
required for kinase activation (Fig. 2 B).
We also tested the role of prolines in the CD2-5 peptide
for Fyn activation. Because the CD2-5 peptide contains
two potential SH3-binding proline motifs, we synthesized
two peptides with each of the pairs of prolines substituted
 
with alanine residues. Although both mutant peptides were
significantly impaired in their ability to stimulate Fyn kinase
activity, the P306,309A peptide demonstrated a greater im-
pairment than the P297,300A peptide (Fig. 2 C). This data
suggests that the proline motif between residues 306 and
309 is the primary Fyn-activating motif.
 
Lck Binds to the Sequence Corresponding to the CD28-2 Pep-
tide.
 
The sequence of the CD28-2 peptide corresponds to
the last 20 residues of the CD28 cytoplasmic domain. To
determine whether Lck can bind to this portion of CD28,
two GST fusion proteins were generated that contain either
the complete cytoplasmic domain of CD28 (GST-CD28)
or the cytoplasmic domain lacking the last 16 residues
(GST-
 
D
 
C). Both proteins were incubated with Sf9 cell ly-
sate containing exogenously expressed Lck. GST proteins
were isolated and Lck binding was assessed by in vitro ki-
nase assay measuring Lck autophosphorylation (Fig. 3 A) or
by using a specific tyrosine kinase peptide as a substrate
(Fig. 3 B). As shown in Fig. 3, Lck tyrosine kinase activity
coprecipitated with the full length but not the truncated
form of CD28. Partial V8 protease mapping confirmed the
identity of the putative autophosphorylated band as Lck
(data not shown). In addition, no tyrosine kinase activity
was detected after the fusion proteins were incubated in
cell lysates lacking Lck (data not shown). Thus, Lck inter-
acts with CD28 and, specifically, the sequence correspond-
ing to the CD28-2 peptide.
 
CD28 Molecules Lacking Prolines 187 and 190 Are Defective
in Their Ability to Stimulate a c-fos Reporter Construct.
 
Upon
binding of a ligand, CD80 or CD86, CD28-mediated sig-
nals cooperate with signals transduced by the TCR, result-
ing in IL-2 production, CD25 expression, cell cycle pro-
gression, and cell survival (for review see references 19 and 20).
As activation of Lck results in mitogen-activated protein
(MAP) kinase induction, and because c-fos is stimulated in
response to MAP kinase activation (21), we reasoned that if
CD28 activates Lck, CD28 engagement should induce expres-
sion of a c-fos reporter plasmid. Furthermore, Lck-dependent
MAP kinase activation in T cells has been shown to be de-
pendent on the SH3 domain of Lck (22).
Wild-type mCD28 or the mutated mCD28 construct
were transiently cotransfected into Jurkat cells with the c-fos
reporter plasmid. Flow cytometry was used to verify equiva-
lent mCD28 surface expression, and a control expression plas-
mid (renilla luciferase) was used to normalize transfection
efficiency (data not shown). In the absence of antibody liga-
tion, overexpression of wild-type mCD28 stimulated the
activity of the c-fos promoter approximately four–fivefold.
Treatment with soluble anti-CD28 monoclonal antibodies,
however, strongly stimulated the c-fos reporter plasmid 10–
12-fold (Fig. 4 A).
We next focused on determining whether prolines 187
and 190 were critical for CD28 function. A mutated form
of CD28 was generated with alanines substituted for pro-
lines 187 and 190. The mutated form of mCD28 was then
tested for its ability to stimulate the c-fos reporter. P187,
190A was significantly impaired in its ability to induce the
c-fos promoter, both in the presence and absence of CD28
Figure 2. Proline residues are required to activate Lck and Fyn. (A) Se-
quences of mutated CD2 and CD28 peptides used are depicted using the
one-letter amino acid code. The mutated residues are shown in bold. (B)
Activation of Lck kinase activity by CD28 peptide requires proline resi-
dues. Kinase reactions were performed as described in Fig. 1 using wild-
type and mutated CD28 peptides. (C) Activation of Fyn kinase activity by
CD2 peptide requires proline residues. Kinase reactions were performed
as described in Fig. 1 using wild-type and mutated CD2 peptides. All data
are representative of at least three independent trials. 
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antibodies (Fig. 4 A). In repeated experiments, P187,190A
always induced at significantly lower levels, even when ex-
pression was as high or higher than wild-type CD28. We
suspect that some of the activity measured with this mutant
may be due to formation of heterodimers with wild-type
CD28 molecules. Nevertheless, these data clearly demon-
strate that the proline residues required to activate Lck kinase
activity are important for CD28 signaling in Jurkat cells.
 
CD28 Induction of c-fos Requires Lck. 
 
To determine
whether  CD28 induction of c-fos required Lck, wild-type
mCD28 was cotransfected with the c-fos reporter into
JCaM1.6 cells, which lack functional Lck (23). No detect-
able c-fos reporter activity was measured both in the pres-
ence or absence of anti-CD28 antibodies (Fig. 4 B). The
induction of c-fos was specific for Lck, as reconstitution of
JCaM1.6 cells with wild-type Lck but not Fyn reconsti-
tuted CD28 stimulation of c-fos to levels similar to those of
the parental Jurkat cells (Fig. 5, A and C). This demon-
strates that CD28-mediated stimulation of the c-fos re-
porter requires Lck.
Figure 3. Lck interacts with the last 16 residues in the CD28 tail. (A)
Chimeric GST molecules containing the full length CD28 tail or lacking
the last 16 residues of CD28 (DC) were incubated with Sf9 cell lysates
with or without exogenously expressed Lck. GST fusion proteins were
isolated with glutathione agarose beads and washed three times. In vitro
kinase assays were performed in the presence of [g-32P]ATP. Kinase reac-
tions were analyzed by SDS-PAGE, and Lck autophosphorylation was
quantitated by PhosphorImage analysis. This data is representative of
three independent trials. (B) Procedure was the same as described in A,
except that in vitro kinase assays were performed in the presence of a spe-
cific tyrosine kinase substrate peptide. Kinase reactions were incubated
with 10% TCA to precipitate phosphorylated proteins. Peptide phosphor-
ylation was quantitated after binding to phosphocellulose paper using a
PhosphorImager. Background kinase activity, determined by measuring
activity in reactions prepared with GST alone, was subtracted from all
samples. The data is representative of three independent trials.
Figure 4. CD28-mediated activation of the c-fos promoter requires
prolines 187 and 190 and Lck. (A) CD28 requires prolines 187 and 190
to activate the c-fos promoter. Wild-type and mutated mCD28
(P187,190A) was transiently cotransfected into Jurkat cells with a c-fos re-
porter plasmid. Anti-CD28 mAb (37.51) was added to the media 10–12 h
after electroporation, and cells were harvested and assayed for luciferase
activity 24 h later. CD28 surface expression was verified by flow cytome-
try, and transfections were normalized using a renilla luciferase reporter
plasmid. Data is shown as fold activation compared with unstimulated
cells transfected with the c-fos reporter plasmid alone. (B) CD28 stimula-
tion of the c-fos reporter requires Lck. Wild-type mCD28 was cotrans-
fected with the c-fos reporter plasmid into JCaM1.6 cells, which lack Lck
expression. Experiments were performed as described in A. In this exper-
iment, PMA stimulation of the fos-luciferase (fos-luc) reporter was used
to control for transfection efficiency. All data are representative of at least
three independent trials. 
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To test whether the SH3 domain of Lck was involved in
CD28-mediated c-fos induction, JCaM1.6 cells stably trans-
fected with a form of Lck containing a mutation in the
SH3 domain (W97A) were tested for the ability of CD28
to stimulate c-fos. mCD28 did not induce the c-fos reporter
in this cell line, even in the presence of cross-linking anti-
bodies (Fig. 5 B). Thus, an intact Lck SH3 domain is re-
quired for CD28 induction of c-fos.
 
Reconstitution of T Cells from CD28-deficient Mice Confirms
the Requirement for Prolines 187 and 190 of CD28.
 
As CD28
costimulation is most important for the activation of naive
T cells, our current studies in transformed cell lines may not
accurately reflect the true biological role of CD28 in primary
cells. To examine the importance of the proline residues in
CD28 signaling in primary T cells, we reconstituted T cells
from CD28 knockout animals using retroviruses expressing
either wild-type or mutated mCD28.
Retroviruses were prepared encoding either wild-type
mCD28 or mutated forms of mCD28 either lacking the
COOH-terminal 16 residues (
 
D
 
16) or with prolines 187
and 190 substituted with alanines (P187,190A). Lymph node
T cells from CD28 knockout mice were infected with wild-
type or mutated forms of CD28 using retroviral infection.
Flow cytometry demonstrated similar levels of expression
and similar mean fluorescence intensities of all the mCD28
constructs, with 
 
z
 
10–15% of T cells positive for CD28 ex-
pression (data not shown).
To test the function of CD28, infected T cells were
stimulated with anti-CD3 antibodies, PMA, or a combina-
tion of anti-CD3 or PMA and antibodies to CD28. As ex-
pected, cells infected with the control retrovirus prolifer-
ated weakly upon treatment with anti-CD3 or PMA alone,
and this effect was not enhanced by coculture with anti-
bodies to CD28 (Fig. 6). T cells infected with the retrovirus
encoding wild-type mCD28 proliferated strongly with both
the combination of anti-CD3 or PMA and antibodies to
CD28, whereas cells expressing the truncated form of
CD28 or the P187,190A construct completely failed to re-
spond to the addition of CD28 antibodies (Fig. 6). We sus-
pect that the enhanced proliferation of anti-CD3 in cells
expressing wild-type mCD28 is due to the presence of B7-
positive cells in our cultures. Thus, the ability of CD28 to
signal in primary T cells requires the COOH terminus of
CD28, and specifically prolines 187 and 190.
 
Primary T Cells Lacking Lck Are Unable to Proliferate in Response
to PMA and CD28.
 
To verify that Lck is indeed required
for CD28-mediated proliferation of primary T cells, we
also examined CD28 signaling in T cells from Lck knock-
out mice (24). Peripheral T cells from the Lck-deficient
mice were harvested and tested for their ability to prolifer-
ate in response to anti-murine CD28 antibodies and PMA.
As expected, wild-type cells strongly proliferated in re-
sponse to PMA and anti-CD28 (Fig. 7). T cells from ho-
mozygous Lck-deficient mice did not respond to PMA and
 
Figure 5.
 
CD28-mediated activation of c-fos requires the SH3 domain
of Lck and cannot be reconstituted by Fyn. (A) Reconstitution of Lck-
deficient Jurkat cells with wild-type Lck rescues CD28 stimulation of the
c-fos reporter. Wild-type mCD28 was cotransfected with the c-fos re-
porter plasmid into JCaM1.6 cells stably transfected with Lck. Experi-
ments were performed as described for Fig. 3 A. (B) Lck-deficient Jurkat
cells reconstituted with Lck SH3 point mutants (W97A) do not allow
CD28 to drive the c-fos reporter. Wild-type mCD28 was cotransfected
with the c-fos reporter plasmid into JCaM1.6 cells stably transfected with
Lck W97A SH3 mutant. Experiments were performed as for Fig. 3 A. In
this experiment, PMA stimulation of the fos-luciferase (fos-luc) reporter
was used to control transfection efficiency. (C) Overexpression of Fyn in
Lck-deficient Jurkat cells cannot reconstitute CD28 c-fos induction.
JCaM1.6 cells stably overexpressing wild-type Fyn were transiently
cotransfected with the c-fos reporter as in Fig. 3 A. In this experiment,
PMA stimulation of the fos-luciferase reporter was used to control trans-
fection efficiency. All data are representative of three independent trials. 
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anti-CD28 (Fig. 7). Importantly, mice heterozygous for
Lck expression showed a decreased response to PMA and
anti-CD28 (Fig. 7), proliferating about half as well as wild-
type cells. As T cells from Lck-heterozygous mice are phe-
notypically normal, the decreased response to CD28 signal-
ing is not related to abnormalities in T cell development.
These findings confirm our results obtained in Jurkat cell
lines and demonstrate clearly that Lck is required for CD28
signaling in primary T cells.
 
Discussion
 
To date, the role of SH3 domain–mediated activation of
Src kinases has not been tested as a model for Src kinase ac-
tivation in vivo. Previous studies used an artificial, high af-
finity SH3-binding peptide or a viral protein, HIV-Nef, to
study Hck kinase activation (8, 9). Here we have demon-
strated that sequences from cellular proteins known to be
involved in T cell activation can function as activators of
Fyn and Lck kinases via their interactions with SH3 domains.
These data support a model where engagement of the
SH3 domains of Lck and Fyn by T cell accessory molecules
plays an important role in kinase activation during T cell
activation. Recruitment and clustering of CD2 and CD28
with the TCR into the T cell contact cap (25) could po-
tentially bring together Lck (associated with CD4 and CD8)
and Fyn (associated with the TCR) with their respective
activating ligands contained in CD2 and CD28. Although
the millimolar concentrations of peptide required to acti-
vate the Src kinases in vitro seem high, these concentra-
tions are probably in the physiological range. As both CD28
and Lck are membrane-bound proteins, both molecules are
concentrated in two-dimensional space and rotationally
constrained. It has been estimated that a 1-mM concentra-
tion of CD28 corresponds to a density of 
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600 molecules/
 
m
 
m
 
2
 
 (26). Given that the resting density of CD28 is 
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100–
200 molecules/
 
m
 
m
 
2
 
, clustering of membrane proteins could
easily attain concentrations sufficient to activate Lck and
Fyn. These calculations can also explain why overexpres-
sion of CD28 in our transient expression is able to stimulate
the c-fos reporter. Thus, the concentration of peptide re-
quired to activate Lck and Fyn is in the appropriate physio-
logical range.
Although the magnitude of SH3-mediated activation
seems low, 
 
z
 
2.5–3-fold, it is similar to the level of activa-
tion induced by COOH-terminal tyrosine dephosphoryla-
tion, which is sufficient to transform cells (1–3). Indeed,
engagement of the SH3 domain is sufficient by itself to in-
duce transformation of fibroblast cells (9). This low magni-
tude of activation can also potentially explain difficulties in
demonstrating Lck and Fyn activation induced by TCR,
CD2, or CD28 engagement. Although several groups have
reported activation of Lck and Fyn after cross-linking of
various T cell membrane proteins (15–18, 27–30), the lev-
els of activation are low and have been difficult to repro-
duce. However, as only a fraction of kinase molecules are
likely to be activated by specific transmembrane proteins, it
is not surprising that a relatively small increase in kinase ac-
tivity would be difficult to be detect.
Figure 6. Reconstitution of CD28 signaling in T cells from CD28-
deficient mice requires proline residues at positions 187 and 190. Lymph
node T cells from CD28-deficient animals were infected with retroviruses
encoding either wild-type mCD28 or mCD28 lacking the 16 COOH-
terminal residues (D16) or with the P187,190A mutated construct. 3 d af-
ter infection, T cells were stimulated with anti-CD3 antibodies, PMA, or
anti-CD3 and PMA in combination with antibodies to mCD28. T cell
proliferation was measured by [3H]thymidine incorporation. Retroviral
transduction efficiency was measured by analyzing mCD28 surface ex-
pression using flow cytometry. Values are the means of quadruplicate
samples. The data is representative of three independent experiments.
Figure 7. T cells from the Lck-deficient mouse are defective in their
response to PMA and anti-CD28. Peripheral T cells from wild-type
C57BL/6, Lck heterozygotes, or Lck-deficient animals were harvested
and plated at 7.5 3 104 cells per well in a 96-well round-bottom plate.
Cells were stimulated with antibodies to CD28 alone (l mg/ml) or anti-
CD28 plus 5 ng/ml PMA. 24 h later, cells were pulsed with [3H]thymi-
dine and harvested after 12 h of incubation. Lck2/2 A and B represent
two different Lck-deficient mice. Values are the means of triplicate sam-
ples. These results are representative of two independent experiments.382 Lck Is Required for CD28 Costimulation
The observation that Lck and Fyn are specifically acti-
vated by proline residues in CD28 and CD2, respectively,
raises the question of whether the SH3 domains of Lck and
Fyn have different affinities for the proline regions of CD28
and CD2. To address this issue, we measured the affinities
of purified Lck and Fyn SH3 domains to the CD28-2 and
CD2-5 peptides by both surface plasmon resonance and
fluorescence anisotropy. Similar results were obtained with
both SH3 domains for both peptides (12–20 mM; data not
shown). These values are in the range of other published
studies for SH3 domain–proline interactions (14, 31) and
suggest that the activation of these tyrosine kinases is not
due to differential affinities of the SH3 domains for the pro-
line regions. Rather, activation may be dependent on the
ability of a specific peptide to displace the SH2 linker region
from the kinase lobe.
Others have previously demonstrated association of
CD28 with Lck in T cells and activation of Lck after CD28
cross-linking (15, 28). The mechanism of activation, how-
ever, was unknown. Previous mapping studies in Jurkat
cells showed that truncating 10 or 17 residues of the CD28
tail, but not 5 residues, could abrogate CD28 function (32,
33). This suggests that a critical sequence for CD28 function
lies between the last 6 to 17 residues of the CD28 cytoplas-
mic domain. Our studies extend previous mapping data by
demonstrating that Lck can bind to this sequence and im-
plicate two proline residues (P187 and P190), which are
contained between the last 6–17 residues of CD28, as criti-
cal for CD28 function.
To verify the physiological relevance of this interaction,
we demonstrated that CD28 engagement by itself could
stimulate a c-fos reporter. This reporter induction was de-
pendent on the presence of wild-type Lck. CD28 in Jurkat
T cells lacking Lck (JCaM1.6) (23) or expressing an SH3-
mutated form of Lck (22) were unable to stimulate the
c-fos reporter. This observation clearly demonstrates a re-
quirement for Lck in this pathway. These studies demon-
strate that c-fos induction by CD28 is specific to Lck, as
JCaM1.6 cells express abundant amounts of Fyn (34). Fur-
thermore, overexpression of Fyn in JCaM1.6 cells did not
reconstitute the ability of CD28 to induce c-fos expression
(data not shown).
Previous studies had shown that JCaM1.6 cells lacking
Lck can signal normally through CD28 (35). These studies,
however, focused on a different readout for CD28 func-
tion, namely the production of IL-2 by coengagement of
CD28. Here we used a readout that allows us to measure
signals mediated by CD28 engagement by itself; in our
studies, we did not require coengagement with the TCR.
The requirement for Lck is strongly supported by our ob-
servation that primary T cells lacking Lck could not re-
spond to anti-CD28 plus PMA. More importantly, CD28
stimulation was reduced by half in mice that are heterozy-
gous for Lck expression. As T cells from heterozygous ani-
mals are otherwise phenotypically normal (24), this reduc-
tion in stimulation demonstrates genetically that there is a
strong dose effect for Lck in CD28 costimulation.
Although we demonstrated that Lck can bind to the last
16 residues of CD28, Lck may interact with other domains
of CD28. For example, CD28 is known to be tyrosine
phosphorylated during T cell activation (36, 37) and could
therefore interact with the Lck SH2 domain. Such an in-
teraction could facilitate recruitment of Lck to CD28. This
seems plausible, as the SH2 affinities are generally much
higher than the typical SH3 interaction. In addition, as
resting T cells mostly lack Lck COOH-terminal tyrosine
phosphorylation, the SH2 domain should be unliganded
and available for binding. It will be interesting to determine
whether tyrosine phosphorylation of CD28 cooperates with
the proline motif to enhance Lck activity during T cell ac-
tivation.
CD28 and T Cell Costimulation. Although extensively
studied, the exact nature of T cell costimulation by CD28
remains unclear. Costimulation was originally defined as a
distinct signal required in conjunction with the signal trans-
duced by the TCR for the initial activation of naive T cells
(38). As engagement of CD28 by antibodies or its ligand,
B7, can block the induction of T cell anergy (38), CD28 is
thought to transduce unique signals that are required for T
cell activation.
Extensive studies on CD28 signaling have demonstrated
potential involvement of CD28 in a variety of signaling
pathways. Many studies have focused on transcription fac-
tors induced by CD28. These include the c-fos/c-jun hetero-
dimer, activator protein 1 (33, 39), as well as the latent
transcription factor, nuclear factor kB (33, 40, 41). How-
ever, in most of these cases, signals detected by CD28 en-
gagement require coengagement with the TCR. However,
several groups have shown that CD28 cross-linking by it-
self can induce tyrosine phosphorylation (15, 28, 42–44). In
support of this, tyrosine kinase inhibitors can block CD28
costimulation (45, 46). The interactions between CD28 and
Lck described here are consistent with this data.
Some of the difficulty in understanding the role of CD28
in costimulation may be due to the fact that most studies of
CD28 were performed in transformed T cell lines such as
Jurkat, which do not require costimulation for activation
and cannot be anergized. Thus, the requirements for CD28
function defined in Jurkat cells may not be the same as in
primary T cells. Our reconstitution of CD28-deficient T
cells with wild-type and mutated CD28 molecules is the
first study, to our knowledge, to define structural features
of CD28 in primary nontransformed T cells.
Our data are consistent with the idea that CD28 does
not transduce a unique signal. Rather, our data supports the
idea that CD28 costimulation functions mainly to enhance
TCR signaling. By binding to its ligand, B7, on the APC,
CD28 could strengthen adhesion of T cells with APCs, po-
tentiating TCR engagement with antigen. By activating
Lck, CD28 could also enhance and amplify tyrosine phos-
phorylation events induced by TCR engagement. In sup-
port of a model where CD28 functions mainly to potenti-
ate signals transduced by the TCR, two recent studies
demonstrate that CD28 stimulates a transport mechanism
that recruits lipid rafts to the contact surface between the T
cell and the APC (47, 48). One consequence of this recruit-383 Holdorf et al.
ment is enhanced tyrosine phosphorylation and increased
consumption of Lck (48). These data are consistent with the
role for Lck that we propose here. Our data, however, can-
not rule out the possibility that CD28 transduces other sig-
nals in addition to Lck activation.
Here we have shown that SH3 binding motifs contained
in the cytoplasmic domain of T cell transmembrane pro-
teins can potentially activate Src family tyrosine kinases in T
cells. This finding suggests that the formation of the immu-
nological synapse, a key event in T cell activation, may
have effects in addition to stabilizing cell–cell contacts (49).
The recruitment and concentration of small molecules like
CD2 and CD28 may also result in the activation of the ty-
rosine kinases involved in transducing the earliest signals
mediated by the TCR. Focusing on the costimulation pro-
tein CD28, we demonstrated that CD28 engagement acti-
vates Lck based on the ability of CD28 to induce c-fos ac-
tivity in a proline and Lck SH3–dependent manner. More
importantly, we confirmed these findings in primary T cells
by showing that CD28 signaling required prolines 187 and
190 in CD28 as well as the presence of Lck. This data pro-
vides novel mechanistic insights into CD28 function and
may lead to a better understanding of how Src kinases are
regulated in other cell types.
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